Results: 371

Variables associated with the prevalence of anti-Leishmania spp. antibodies in dogs on the tri-border of Foz do Iguaçu, Paraná, Brazil

Abstract The aim of this study was to investigate the occurrence of anti-Leishmania spp. antibodies in dogs from localities in the city of Foz do Iguaçu, Paraná state, Brazil, on the border with Argentina and Paraguay. Blood samples dogs were collected to perform the following serologic tests: immunoc...

Spatio-temporal analysis of the occurrence of human visceral leishmaniasis in Araçatuba, State of São Paulo, Brazil

Abstract INTRODUCTION: This study aimed to describe the occurrence of human visceral leishmaniasis in Araçatuba with regard to time and space and to identify high risk areas. METHODS: We included all human visceral leishmaniasis autochthonous cases reported between 1999 and 2015. The incidence rates...

Epidemiology of human visceral leishmaniasis in the urban centers of the lower-middle São Francisco Valley, Brazilian semiarid region

Abstract INTRODUCTION: Visceral leishmaniasis (VL) is a zoonosis caused by parasites of the Leishmania genus. VL is present in countries with tropical climates, being endemic in Brazil,, including the region of the lower-middle São Francisco Valley which includes the urban centers of Petrolina (Pernamb...

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Abstract Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema. In this study, we discuss a case of a 1-year-old child diagnosed with refractory visceral leishmaniasis...

Immunohaematological and rheological parameters in canine visceral leishmaniasis

Abstract The aim of this study was to find correlations between haematological and rheological parameters in canine visceral leishmaniasis (CLV). Enrolled dogs with CVL (n=31) had a confirmed diagnosis using the rapid test Dual Path Platform (TR DPP®) kit and Polymerase Chain Reaction (PCR) assay. A co...

O papel da vigilância entomológica no primeiro foco ativo urbano de leishmaniose visceral do município do Rio de Janeiro

ABCS health sci; 43 (1), 2018
INTRODUÇÃO: A leishmaniose Visceral (LV) é uma antropozoonose causada pela Leishmania infantum que avança nos últimos trinta anos a passos largos em sentido ao ambiente urbano. Desde 1977 há registros da doença em áreas periféricas do município do Rio de Janeiro, entretanto em 2011 foi descrita...

Visceral Leishmaniasis hospitalizations and seasonality in Fortaleza, Ceará, Northeast Brazil between 2003 – 2012

Introduction: The knowledge of the relationship between Visceral Leishmaniosis and climatic aspects is already well established in the literature of other countries, but lack data of this relationship in Brazil. Objective: This study aimed to describe the seasonal distribution of hospitalizations for Vis...

Leishmaniose visceral humana: estudo do perfil clínico-epidemiológico na região leste de Minas Gerais, Brasil

Introdução: Leishmaniose Visceral (LV) é uma doença sistêmica que afeta animais e o homem. Incluída entre as seis doenças endêmicas mais importantes no mundo, é de notificação compulsória e apresenta número elevado de óbitos. Objetivo: Descrever o perfil clínico-epidemiológico dos casos n...

Potential application of rLc36 protein for diagnosis of canine visceral leishmaniasis

Mem. Inst. Oswaldo Cruz; 113 (3), 2018
Visceral leishmaniasis (VL) is fatal if left untreated. Infected dogs are important reservoirs of the disease, and thus specific identification of infected animals is very important. Several diagnostic tests have been developed for canine VL (CVL); however, these tests show varied specificity and sensiti...

Is Visceral Leishmaniasis the same in HIV-coinfected adults?

Braz. j. infect. dis; 22 (2), 2018
ABSTRACT Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania donovani complex, with significant morbidity and mortality in developing countries. Worse outcomes occur among HIV-positive individuals coinfected with Leishmania. It is unclear, however, if there a...